Invention Grant
- Patent Title: IL-17A-binding polypeptides
-
Application No.: US15538890Application Date: 2016-01-12
-
Publication No.: US10934335B2Publication Date: 2021-03-02
- Inventor: Fredrik Frejd , Joachim Feldwisch , Susanne Klint , Lindvi Gudmundsdotter
- Applicant: AFFIBODY AB
- Applicant Address: SE Solna
- Assignee: AFFIBODY AB
- Current Assignee: AFFIBODY AB
- Current Assignee Address: SE Solna
- Agency: Cantor Colburn LLP
- Priority: EP15150786 20150112
- International Application: PCT/EP2016/050456 WO 20160112
- International Announcement: WO2016/113246 WO 20160721
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/54 ; C07K14/745 ; A61K38/20
Abstract:
The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-17A (IL-17A), and provides an IL-17A binding polypeptide comprising the sequence EX2DX4AX6X7EIX10X11 LPNL X16X17X18QX20X21AFIX25 X26LX28X29. Also disclosed is the use of such an interleukin-17A binding polypeptide as a diagnostic, prognostic and/or therapeutic agent.
Public/Granted literature
- US20170362290A1 IL-17A-BINDING POLYPEPTIDES Public/Granted day:2017-12-21
Information query
IPC分类:
